Skip to main content
SpringerLink
Log in

Effect of Sex Hormones on the ABCG2 Transport Protein in Caco-2 Cells

  • Published:
Biochemistry (Moscow), Supplement Series A: Membrane and Cell Biology Aims and scope

Abstract—

ABCG2 protein (breast cancer resistance protein, BCRP) is an efflux transmembrane protein involved in the transport of endogenous and exogenous substances, as well as in the development of tumor resistance to chemotherapy. In this work, the effects of sex hormones progesterone, estradiol, and testosterone on the relative content of ABCG2 in Caco-2 cells was evaluated. The role of orphan receptors (farnasoid X receptor (FXR), constitutive androstane receptor (CAR), pregnane X receptor (PXR), and liver X receptor subtype alpha (LXRα) in the effects of sex hormones was also studied. The content of ABCG2 was estimated by the Western blot technique. Hormones were used at concentrations of 1, 10, and 100 μM; exposure duration was 24 h. All hormones at all concentrations caused an increase in the content of ABCG2. Inhibition of PXR and FXR prevented an increase in ABCG2 levels induced by progesterone. Suppression of CAR and PXR partially reduced the expression of ABCG2 caused by estradiol, as compared to exposure to estrogen alone, but still the level of the transporter exceeded the control. Inhibition of PXR and FXR attenuated the inducing effect of testosterone; however, the level of the transporter exceeded the control. Thus, it was shown that all sex hormones at concentrations 1, 10, and 100 μM increased the content of ABCG2. CAR and PXR participated in the action of estradiol, while FXR and PXR participated in the action of testosterone and progesterone.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1.
Fig. 2.
Fig. 3.
Fig. 4.

Similar content being viewed by others

REFERENCES

  1. Doyle L.A., Yang W., Abruzzo L.V., Krogmann T., Gao Y., Rishi A.K., Ross D.D. 1998. A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc. Natl. Acad. Sci. USA. 95 (26), 15 665–15 670. https://doi.org/10.1073/pnas.95.26.15665

    Article  Google Scholar 

  2. Khunweeraphong N., Stockner T., Kuchler K. 2017. The structure of the human ABC transporter ABCG2 reveals a novel mechanism for drug extrusion. Sci. Rep. 7 (1), 13767. https://doi.org/10.1038/s41598-017-11794-w

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Rosenberg M.F., Bikadi Z., Chan J., Liu X., Ni Z., Cai X., Ford R.C., Mao Q. 2010. The human breast cancer resistance protein (BCRP/ABCG2) shows conformational changes with mitoxantrone. Structure. 18 (4), 482–493. https://doi.org/10.1016/j.str.2010.01.017

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Ni Z., Bikadi Z., Rosenberg M.F., Mao Q. 2010. Structure and function of the human breast cancer resistance protein (BCRP/ABCG2). Cur. Drug Metabolism. 11 (7), 603–617. https://doi.org/10.2174/138920010792927325

    Article  CAS  Google Scholar 

  5. Maliepaard M., Scheffer G.L., Faneyte I.F., van Gastelen M.A., Pijnenborg A.C., Schinkel A.H., van De Vijver M.J., Scheper R.J., Schellens J.H. 2001. Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues. Cancer Res. 61 (8), 3458–3464.

    CAS  PubMed  Google Scholar 

  6. Natarajan K., Xie Y., Baer M.R., Ross D.D. 2012. Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance. Biochem. Pharm. 83 (8), 1084–1103. https://doi.org/10.1016/j.bcp.2012.01.002

    Article  CAS  PubMed  Google Scholar 

  7. Stiburkova B., Pavelcova K., Zavada J., Petru L., Simek P., Cepek P., Pavlikova M., Matsuo H., Merriman T.R., Pavelka K. 2017. Functional non-synonymous variants of ABCG2 and gout risk. Rheumatology (Oxford). 56 (11), 1982–1992. https://doi.org/10.1093/rheumatology/kex295

    Article  CAS  PubMed  Google Scholar 

  8. Ee P.L., Kamalakaran S., Tonetti D., He X., Ross D.D., Beck W.T. 2004. Identification of a novel estrogen response element in the breast cancer resistance protein (ABCG2) gene. Cancer Res. 64 (4), 1247–1251. https://doi.org/10.1158/0008-5472.can-03-3583

    Article  CAS  PubMed  Google Scholar 

  9. Yasuda S., Kobayashi M., Itagaki S., Hirano T., Iseki K. 2009. Response of the ABCG2 promoter in T47D cells and BeWo cells to sex hormone treatment. Mol. Biol. Rep. 36 (7), 1889–1896. https://doi.org/10.1007/s11033-008-9395-0

    Article  CAS  PubMed  Google Scholar 

  10. Evseenko D.A., Paxton J.W., Keelan J.A. 2007. Independent regulation of apical and basolateral drug transporter expression and function in placental trophoblasts by cytokines, steroids, and growth factors. Drug Metab. Dispos. 35 (4), 595–601. https://doi.org/10.1124/dmd.106.011478

    Article  CAS  PubMed  Google Scholar 

  11. Wang H., Zhou L., Gupta A., Vethanayagam R.R., Zhang Y., Unadkat J.D., Mao Q. 2006. Regulation of BCRP/ABCG2 expression by progesterone and 17beta-estradiol in human placental BeWo cells. Amer. J. Physiol. Endocrinol. Metabol. 290 (5), 798–807. https://doi.org/10.1152/ajpendo.00397.2005

    Article  CAS  Google Scholar 

  12. Wang H., Lee E.W., Zhou L., Leung P.C., Ross D.D., Unadkat J.D., Mao Q. 2008. Progesterone receptor (PR) isoforms PRA and PRB differentially regulate expression of the breast cancer resistance protein in human placental choriocarcinoma BeWo cells. Mol. Pharm. 73 (3), 845–854. https://doi.org/10.1124/mol.107.041087

    Article  CAS  Google Scholar 

  13. Wu X., Zhang X., Sun L., Zhang H., Li L., Wang X., Li W., Su P., Hu J., Gao P., Zhou G. 2013. Progesterone negatively regulates BCRP in progesterone receptor-positive human breast cancer cells. Cell Physiol. Biochem. 32 (2), 344–354. https://doi.org/10.1159/000354442

    Article  CAS  PubMed  Google Scholar 

  14. Wu X., Zhang X., Zhang H., Su P., Li W., Li L., Wang Y., Liu W., Gao P., Zhou G. 2012. Progesterone receptor downregulates breast cancer resistance protein expression via binding to the progesterone response element in breast cancer. Cancer Sci. 103 (5), 959–967. https://doi.org/10.1111/j.1349-7006.2012.02245.x

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Mazaira G.I., Zgajnar N.R., Lotufo C.M., Daneri-Becerra C., Sivils J.C., Soto O.B., Cox M.B., Galigniana M.D. 2018. The nuclear receptor field: A historical overview and future challenges. Nucl. Receptor Res. 5, 101320. https://doi.org/10.11131/2018/101320

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Shi Y. 2007. Orphan nuclear receptors in drug discovery. Drug Discov. Today. 12 (11–12), 440–445. https://doi.org/10.1016/j.drudis.2007.04.006

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Serviddio G., Bellanti F., Vendemiale G. 2014. Oxysterols in the orchestra of liver cell metabolism. Free Radic. Biol. Med. 1, S6. https://doi.org/10.1016/j.freeradbiomed.2014.10.838

    Article  Google Scholar 

  18. Chiang J.Y.L., Ferrell J.M. 2022. Discovery of farnesoid X receptor and its role in bile acid metabolism. Mol. Cell Endocrinol. 548, 111618. https://doi.org/10.1016/j.mce.2022.111618

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Krasowski M.D., Ni A., Hagey L.R., Ekins S. 2011. Evolution of promiscuous nuclear hormone receptors: LXR, FXR, VDR, PXR, and CAR. Mol. Cell Endocrinol. 334 (1–2), 39–48. https://doi.org/10.1016/j.mce.2010.06.016

    Article  CAS  PubMed  Google Scholar 

  20. Jin B., Wang W., Bai W., Zhang J., Wang K., Qin L. 2017. The effects of estradiol valerate and remifemin on liver lipid metabolism. Acta Histochem. 119 (6), 610–619. https://doi.org/10.1016/j.acthis.2017.06.004

    Article  CAS  PubMed  Google Scholar 

  21. Kawamoto T., Kakizak S., Yoshinari K., Negishi M. 2000. Estrogen activation of the nuclear orphan receptor CAR (constitutive active receptor) in induction of the mouse CYP2B10 gene. Mol. Endocrinol. 14, 1897–1905. https://doi.org/10.1210/mend.14.11.0547

    Article  CAS  PubMed  Google Scholar 

  22. Blumberg B., Sabbagh W., Juguilon H., Bolado J., van Meter C.M., Ong E.S., Evans R.M. 1998. SXR, a novel steroid and xenobiotic sensing nuclear receptor. Genes Dev. 12 (20), 3195–3205. https://doi.org/10.1101/gad.12.20.3195

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Milona A., Owen B.M., Cobbold J.F., Willemsen E.C., Cox I.J., Boudjelal M., Cairns W., Schoonjans K., Taylor-Robinson S.D., Klomp L.W., Parker M.G., White R., van Mil S.W., Williamson C. 2010. Raised hepatic bile acid concentrations during pregnancy in mice are associated with reduced farnesoid X receptor function. Hepatology. 52 (4), 1341–1349. https://doi.org/10.1002/hep.23849

    Article  CAS  PubMed  Google Scholar 

  24. Wang S., Lai K., Moy F.J., Bhat A., Hartman H.B., Evans M.J. 2006. The nuclear hormone receptor farnesoid X receptor (FXR) is activated by androsterone. Endocrinology. 147 (9), 4025–4033. https://doi.org/10.1210/en.2005-1485

    Article  CAS  PubMed  Google Scholar 

  25. Hilgers A.R., Conradi R.A., Burton P.S. 1990. Caco-2 cell monolayers as a model for drug transport across the intestinal mucosa. Pharmac. Res. 7 (9), 902–910. https://doi.org/10.1023/A:1015937605100

    Article  CAS  Google Scholar 

  26. Sim W.C., Kim D.G., Lee K.J., Choi Y.J., Choi Y.J., Shin K.J., Jun D.W., Park S.J., Park H.J., Kim J., Oh W.K., Lee B.H. 2015. Cinnamamides, novel liver X receptor antagonists that inhibit ligand-induced lipogenesis and fatty liver. J. Pharmacol. Exp. Ther. 355 (3), 362–369. https://doi.org/10.1124/jpet.115.226738

    Article  CAS  PubMed  Google Scholar 

  27. Cherian M.T., Lin W., Wu J., Chen T. 2015. CINPA1 is an inhibitor of constitutive androstane receptor that does not activate pregnane X receptor. Mol. Pharmacol. 87 (5), 878–889. https://doi.org/10.1124/mol.115.097782

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Kota B.P., Tran V.H., Allen J., Bebawy M., Roufogalis B.D. 2010. Characterization of PXR mediated P-glycoprotein regulation in intestinal LS174T cells. Pharmacol. Res. 62 (5), 426–431. https://doi.org/10.1016/j.phrs.2010.07.001

    Article  CAS  PubMed  Google Scholar 

  29. Sayin S.I., Wahlström A., Felin J., Jäntti S., Marschall H.U., Bamberg K., Angelin B., Hyötyläinen T., Orešič M., Bäckhed F. 2013. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab. 17 (2), 225–235. https://doi.org/10.1016/j.cmet.2013.01.003

    Article  CAS  PubMed  Google Scholar 

  30. Bradford M.M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 7 (72), 248–254. https://doi.org/10.1006/abio.1976.9999

    Article  Google Scholar 

  31. Nakanishi T., Ross D.D. 2012. Breast cancer resistance protein (BCRP/ABCG2): Its role in multidrug resistance and regulation of its gene expression. Chin. J. Cancer. 31 (2), 73–99. https://doi.org/10.5732/cjc.011.10320

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Wang H., Huang H., Li H., Teotico D.G., Sinz M., Baker S.D., Staudinger J., Kalpana G., Redinbo M.R., Mani S. 2007. Activated pregnenolone X-receptor is a target for ketoconazole and its analogs. Clin. Cancer Res. 13 (8), 2488–2495. https://doi.org/10.1158/1078-0432.CCR-06-1592

    Article  CAS  PubMed  Google Scholar 

  33. Campbell-Thompson M., Lynch I.J., Bhardwaj B. 2001. Expression of estrogen receptor (ER) subtypes and ERbeta isoforms in colon cancer. Cancer Res. 61 (2), 632–640.

    CAS  PubMed  Google Scholar 

  34. Gu S., Papadopoulou N., Gehring E.M., Nasir O., Dimas K., Bhavsar S.K., Föller M., Alevizopoulos K., Lang F., Stournaras C. 2009. Functional membrane androgen receptors in colon tumors trigger pro-apoptotic responses in vitro and reduce drastically tumor incidence in vivo. Mol. Cancer. 8, 114. https://doi.org/10.1186/1476-4598-8-114

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Mahbub A.A. 2022. Therapeutic strategies and potential actions of female sex steroid hormones and their receptors in colon cancer based on preclinical studies. Life (Basel). 12 (4), 605. https://doi.org/10.3390/life12040605

    Article  CAS  PubMed  Google Scholar 

  36. Herraez E., Gonzalez-Sanchez E., Vaquero J., Romero M.R., Serrano M.A., Marin J.J., Briz O. 2012. Cisplatin-induced chemoresistance in colon cancer cells involves FXR-dependent and FXR-independent up-regulation of ABC proteins. Mol. Pharm. 9 (9), 2565–2576. https://doi.org/10.1021/mp300178a

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Ryazan State Medical University named after Academician I.P. Pavlov of the Ministry of Health of Russia, 390026, Ryazan, Russia

    A. A. Slepnev, Yu. V. Abalenikhina, N. M. Popova, A. V. Shchulkin & E. N. Yakusheva

Authors
  1. A. A. Slepnev
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yu. V. Abalenikhina
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. N. M. Popova
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. V. Shchulkin
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. E. N. Yakusheva
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yu. V. Abalenikhina.

Ethics declarations

The authors declare the absence of obvious and potential conflicts of interest related to the publication of this article.

This article does not describe any studies involving humans or animals as objects.

Additional information

Translated by E. Puchkov

Publisher’s Note.

Pleiades Publishing remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Slepnev, A.A., Abalenikhina, Y.V., Popova, N.M. et al. Effect of Sex Hormones on the ABCG2 Transport Protein in Caco-2 Cells. Biochem. Moscow Suppl. Ser. A 17, 293–300 (2023). https://doi.org/10.1134/S1990747823050100

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S1990747823050100

Keywords

Search

Navigation